Compounded semaglutide does expire, and refrigeration significantly slows but does not prevent degradation. Most 503A-compounded formulations remain stable for 30–90 days when stored at 2–8°C, though exact timelines depend on the compounding pharmacy's formulation, container type, and storage protocols—not just temperature alone.
For patients considering compounded semaglutide through PlexusDx, understanding storage stability matters alongside biomarker context. Knowing how long your medication remains potent informs dosing schedules, refill timing, and how your body's individual GLP-1 signaling pathways may interact with consistent medication exposure over weeks.
How 503A Compounding Affects Semaglutide Stability
Licensed 503A compounding pharmacies prepare semaglutide in-house using specific formulation protocols, vehicles, and stabilizers that differ from branded versions. These choices directly impact how quickly the compound degrades in refrigeration. Your pharmacy should provide written stability data and expiration dating unique to their formulation.
Unlike mass-manufactured products with standardized shelf-life testing, compounded medications rely on each pharmacy's quality assurance. PlexusDx partners only with licensed 503A facilities that document their stability research. Always ask your compounding pharmacy for their specific expiration timeline and storage instructions before your prescription is dispensed.
Storage Conditions That Impact Semaglutide Potency
Refrigeration temperature, light exposure, and container integrity all affect how long compounded semaglutide remains therapeutically active. Most 503A formulations require consistent 2–8°C storage; fluctuations or brief room-temperature exposure can accelerate degradation. Even properly refrigerated vials may lose potency if exposed to light or if the seal is compromised.
| Storage Factor |
Impact on Stability |
| Temperature 2–8°C (refrigerator) |
Optimal; slows degradation significantly |
| Temperature 15–25°C (room temp) |
Accelerates breakdown; typically 1–7 days maximum |
| Freezer storage (−20°C or below) |
Not recommended; ice crystal formation damages protein structure |
| Light exposure (UV or direct sunlight) |
Degrades peptide; store in opaque containers |
| Vial seal integrity |
Compromised seals allow oxidation and bacterial entry; reduces stability |
| Typical 503A expiration window |
30–90 days from compounding date, depending on formulation |
Signs Your Compounded Semaglutide May Have Degraded
Visual inspection before each injection is essential. Look for cloudiness, discoloration, visible particles, or separation—any suggest chemical breakdown. Even clear solutions can lose potency without visible signs, which is why adhering to your pharmacy's expiration date is critical for treatment consistency.
If you notice changes in efficacy—reduced appetite suppression, delayed onset, or unusual side effects—expired or improperly stored medication may be a factor. Discuss timing and storage conditions with your provider. Always verify the dispensing date and expiration date on your vial label, and note any storage gaps if you travel.
Planning Your Semaglutide Dosing Schedule Around Stability Windows
Understanding your compounded semaglutide's expiration timeline helps you and your provider coordinate prescription refills and dosing intervals. If your 503A pharmacy's formulation is stable for 60 days, weekly or biweekly injections fit comfortably within that window. Longer intervals between doses may push you past the expiration date.
Patients with slower metabolic responses or those undergoing genetic testing (like PlexusDx's Precision Peptide Genetic Test) may benefit from knowing their predispositions to GLP-1 pathway sensitivity. This context can inform whether shorter or longer treatment cycles suit your individual response pattern, alongside practical storage and expiration considerations.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, and related metabolic pathways—predispositions that may help provide context for how your body responds to consistent GLP-1 exposure over time. While genetic insights do not predict exact medication response, they can support more informed conversations with your provider about treatment duration, dosing frequency, and whether compounded options align with your pathway profile.
The genetic test reveals predispositions in peptide signaling genes such as GLP1R rs6923761 and GIPR rs1800437, among others. This information should be interpreted with a qualified healthcare provider. Genetic predispositions do not determine whether compounded semaglutide will work for you, but they may help contextualize your individual likelihood of benefit and guide whether a longer or shorter treatment window is worth planning around.
When selecting a compounded semaglutide protocol through PlexusDx, understanding both stability windows and your genetic predispositions can support a more personalized conversation with your provider. Together, you can align the 503A pharmacy's expiration timeline with your projected treatment duration and dosing frequency, ensuring medication remains potent throughout your prescribed cycle.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long does compounded semaglutide stay good in the refrigerator?
Most 503A-compounded semaglutide is stable 30–90 days at 2–8°C, depending on the pharmacy's formulation. Your specific expiration date should be clearly labeled on your vial. Ask your compounding pharmacy for their stability data.
What happens if compounded semaglutide freezes?
Freezing damages the peptide structure through ice crystal formation, reducing or eliminating efficacy. Do not intentionally freeze semaglutide. If accidental freezing occurs, discard the vial and contact your pharmacy for replacement.
Can I use compounded semaglutide after the expiration date?
No. After expiration, potency is not guaranteed, and chemical breakdown products may form. Using expired medication may reduce effectiveness or introduce unknown risks. Always follow your pharmacy's expiration date.
Does PlexusDx compounded semaglutide have different storage requirements?
PlexusDx sources compounded semaglutide from licensed 503A pharmacies. Each may have slightly different formulations and expiration windows. You'll receive specific storage and expiration instructions with your dispensed medication.
Can genetic testing help me understand how long I'll need semaglutide treatment?
PlexusDx's Precision Peptide Genetic Test reveals predispositions in GLP-1 pathway genes, which may provide context for your individual likelihood of response. This does not predict exact treatment duration, but your provider can use it alongside clinical assessment to inform realistic timelines.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Last reviewed: May 14, 2026
Last updated: May 14, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Share:
Can You Start Semaglutide at 0.5? An In-Depth Exploration of Dosing and Its Implications
Finding the Right Spot: A Practical Look at Where to Give Ozempic Shot in Leg and Other Effective Injection Areas